Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ATRI's Cash to Debt is ranked higher than
96% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.56 vs. ATRI: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ATRI' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 4.62 Max: No Debt
Current: No Debt
Equity to Asset 0.85
ATRI's Equity to Asset is ranked higher than
84% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. ATRI: 0.85 )
Ranked among companies with meaningful Equity to Asset only.
ATRI' s Equity to Asset Range Over the Past 10 Years
Min: 0.54  Med: 0.80 Max: 0.88
Current: 0.85
0.54
0.88
Interest Coverage No Debt
ATRI's Interest Coverage is ranked higher than
92% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.90 vs. ATRI: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ATRI' s Interest Coverage Range Over the Past 10 Years
Min: 56.67  Med: 10000.00 Max: 9999.99
Current: No Debt
56.67
9999.99
F-Score: 8
Z-Score: 22.19
M-Score: -2.64
WACC vs ROIC
8.23%
23.93%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 29.31
ATRI's Operating margin (%) is ranked higher than
96% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.71 vs. ATRI: 29.31 )
Ranked among companies with meaningful Operating margin (%) only.
ATRI' s Operating margin (%) Range Over the Past 10 Years
Min: 17.61  Med: 26.54 Max: 32.43
Current: 29.31
17.61
32.43
Net-margin (%) 19.80
ATRI's Net-margin (%) is ranked higher than
92% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. ATRI: 19.80 )
Ranked among companies with meaningful Net-margin (%) only.
ATRI' s Net-margin (%) Range Over the Past 10 Years
Min: 12.43  Med: 18.02 Max: 22.12
Current: 19.8
12.43
22.12
ROE (%) 20.01
ATRI's ROE (%) is ranked higher than
88% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. ATRI: 20.01 )
Ranked among companies with meaningful ROE (%) only.
ATRI' s ROE (%) Range Over the Past 10 Years
Min: 15.48  Med: 17.61 Max: 20.41
Current: 20.01
15.48
20.41
ROA (%) 17.38
ATRI's ROA (%) is ranked higher than
95% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. ATRI: 17.38 )
Ranked among companies with meaningful ROA (%) only.
ATRI' s ROA (%) Range Over the Past 10 Years
Min: 12.28  Med: 14.74 Max: 17.56
Current: 17.38
12.28
17.56
ROC (Joel Greenblatt) (%) 41.25
ATRI's ROC (Joel Greenblatt) (%) is ranked higher than
82% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.36 vs. ATRI: 41.25 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ATRI' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 22.31  Med: 39.39 Max: 257.02
Current: 41.25
22.31
257.02
Revenue Growth (3Y)(%) 7.10
ATRI's Revenue Growth (3Y)(%) is ranked higher than
61% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. ATRI: 7.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ATRI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 5.4  Med: 7.40 Max: 41
Current: 7.1
5.4
41
EBITDA Growth (3Y)(%) 4.40
ATRI's EBITDA Growth (3Y)(%) is ranked lower than
52% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. ATRI: 4.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ATRI' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -40.1  Med: 15.55 Max: 131.8
Current: 4.4
-40.1
131.8
EPS Growth (3Y)(%) 3.20
ATRI's EPS Growth (3Y)(%) is ranked higher than
50% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. ATRI: 3.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ATRI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 3.2  Med: 22.00 Max: 59.9
Current: 3.2
3.2
59.9
» ATRI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

ATRI Guru Trades in Q1 2015

Jim Simons 20,700 sh (+10.11%)
Chuck Royce 99,553 sh (-47.15%)
» More
Q2 2015

ATRI Guru Trades in Q2 2015

Jim Simons 24,800 sh (+19.81%)
Chuck Royce 53,900 sh (-45.86%)
» More
Q3 2015

ATRI Guru Trades in Q3 2015

Jim Simons 26,400 sh (+6.45%)
Chuck Royce 52,190 sh (-3.17%)
» More
Q4 2015

ATRI Guru Trades in Q4 2015

Jim Simons 27,800 sh (+5.30%)
Chuck Royce 50,656 sh (-2.94%)
» More
» Details

Insider Trades

Latest Guru Trades with ATRI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 25.70
ATRI's P/E(ttm) is ranked higher than
51% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.14 vs. ATRI: 25.70 )
Ranked among companies with meaningful P/E(ttm) only.
ATRI' s P/E(ttm) Range Over the Past 10 Years
Min: 8.12  Med: 16.52 Max: 27.13
Current: 25.7
8.12
27.13
Forward P/E 26.18
ATRI's Forward P/E is ranked lower than
81% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.84 vs. ATRI: 26.18 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 25.70
ATRI's PE(NRI) is ranked higher than
58% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.14 vs. ATRI: 25.70 )
Ranked among companies with meaningful PE(NRI) only.
ATRI' s PE(NRI) Range Over the Past 10 Years
Min: 8.12  Med: 16.56 Max: 27.13
Current: 25.7
8.12
27.13
P/B 5.15
ATRI's P/B is ranked lower than
94% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.27 vs. ATRI: 5.15 )
Ranked among companies with meaningful P/B only.
ATRI' s P/B Range Over the Past 10 Years
Min: 1.23  Med: 2.75 Max: 5.42
Current: 5.15
1.23
5.42
P/S 5.09
ATRI's P/S is ranked lower than
100% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.86 vs. ATRI: 5.09 )
Ranked among companies with meaningful P/S only.
ATRI' s P/S Range Over the Past 10 Years
Min: 1.3  Med: 3.02 Max: 5.39
Current: 5.09
1.3
5.39
PFCF 26.12
ATRI's PFCF is ranked lower than
51% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.49 vs. ATRI: 26.12 )
Ranked among companies with meaningful PFCF only.
ATRI' s PFCF Range Over the Past 10 Years
Min: 7.41  Med: 19.90 Max: 429.32
Current: 26.12
7.41
429.32
POCF 19.30
ATRI's POCF is ranked lower than
60% of the 205 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.81 vs. ATRI: 19.30 )
Ranked among companies with meaningful POCF only.
ATRI' s POCF Range Over the Past 10 Years
Min: 5.98  Med: 12.64 Max: 23.53
Current: 19.3
5.98
23.53
EV-to-EBIT 16.49
ATRI's EV-to-EBIT is ranked higher than
64% of the 208 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.49 vs. ATRI: 16.49 )
Ranked among companies with meaningful EV-to-EBIT only.
ATRI' s EV-to-EBIT Range Over the Past 10 Years
Min: 1  Med: 10.90 Max: 17.5
Current: 16.49
1
17.5
EV-to-EBITDA 13.71
ATRI's EV-to-EBITDA is ranked higher than
59% of the 227 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.89 vs. ATRI: 13.71 )
Ranked among companies with meaningful EV-to-EBITDA only.
ATRI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 1  Med: 8.70 Max: 14.5
Current: 13.71
1
14.5
PEG 3.17
ATRI's PEG is ranked lower than
51% of the 63 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.97 vs. ATRI: 3.17 )
Ranked among companies with meaningful PEG only.
ATRI' s PEG Range Over the Past 10 Years
Min: 0.22  Med: 1.21 Max: 7.39
Current: 3.17
0.22
7.39
Shiller P/E 35.24
ATRI's Shiller P/E is ranked higher than
53% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 37.26 vs. ATRI: 35.24 )
Ranked among companies with meaningful Shiller P/E only.
ATRI' s Shiller P/E Range Over the Past 10 Years
Min: 14.79  Med: 28.48 Max: 39.09
Current: 35.24
14.79
39.09
Current Ratio 7.09
ATRI's Current Ratio is ranked higher than
90% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. ATRI: 7.09 )
Ranked among companies with meaningful Current Ratio only.
ATRI' s Current Ratio Range Over the Past 10 Years
Min: 1.33  Med: 4.43 Max: 9.73
Current: 7.09
1.33
9.73
Quick Ratio 4.36
ATRI's Quick Ratio is ranked higher than
82% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. ATRI: 4.36 )
Ranked among companies with meaningful Quick Ratio only.
ATRI' s Quick Ratio Range Over the Past 10 Years
Min: 1.16  Med: 2.24 Max: 6.84
Current: 4.36
1.16
6.84
Days Inventory 136.69
ATRI's Days Inventory is ranked lower than
52% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.52 vs. ATRI: 136.69 )
Ranked among companies with meaningful Days Inventory only.
ATRI' s Days Inventory Range Over the Past 10 Years
Min: 114.19  Med: 131.67 Max: 140.27
Current: 136.69
114.19
140.27
Days Sales Outstanding 48.99
ATRI's Days Sales Outstanding is ranked higher than
72% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 64.05 vs. ATRI: 48.99 )
Ranked among companies with meaningful Days Sales Outstanding only.
ATRI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.8  Med: 40.01 Max: 47.49
Current: 48.99
34.8
47.49

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.84
ATRI's Dividend Yield is ranked lower than
70% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.43 vs. ATRI: 0.84 )
Ranked among companies with meaningful Dividend Yield only.
ATRI' s Dividend Yield Range Over the Past 10 Years
Min: 0.67  Med: 0.89 Max: 1.74
Current: 0.84
0.67
1.74
Dividend Payout 0.21
ATRI's Dividend Payout is ranked higher than
80% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.36 vs. ATRI: 0.21 )
Ranked among companies with meaningful Dividend Payout only.
ATRI' s Dividend Payout Range Over the Past 10 Years
Min: 0.04  Med: 0.16 Max: 0.63
Current: 0.21
0.04
0.63
Dividend Growth (3y) 15.20
ATRI's Dividend Growth (3y) is ranked higher than
63% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. ATRI: 15.20 )
Ranked among companies with meaningful Dividend Growth (3y) only.
ATRI' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 15.30 Max: 45.5
Current: 15.2
0
45.5
Forward Dividend Yield 0.92
ATRI's Forward Dividend Yield is ranked lower than
69% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.43 vs. ATRI: 0.92 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.78
ATRI's Yield on cost (5-Year) is ranked higher than
56% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. ATRI: 1.78 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
ATRI' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.4  Med: 1.86 Max: 3.64
Current: 1.78
1.4
3.64
3-Year Average Share Buyback Ratio 0.90
ATRI's 3-Year Average Share Buyback Ratio is ranked higher than
88% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.00 vs. ATRI: 0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ATRI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2.4  Med: 0.00 Max: 12.9
Current: 0.9
-2.4
12.9

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 13.81
ATRI's Price/Net Current Asset Value is ranked lower than
74% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.21 vs. ATRI: 13.81 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ATRI' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 1.58  Med: 9.21 Max: 372
Current: 13.81
1.58
372
Price/Tangible Book 5.64
ATRI's Price/Tangible Book is ranked lower than
64% of the 233 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.21 vs. ATRI: 5.64 )
Ranked among companies with meaningful Price/Tangible Book only.
ATRI' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.54  Med: 2.43 Max: 5.72
Current: 5.64
0.54
5.72
Price/Projected FCF 1.85
ATRI's Price/Projected FCF is ranked lower than
61% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. ATRI: 1.85 )
Ranked among companies with meaningful Price/Projected FCF only.
ATRI' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.74  Med: 1.55 Max: 13.74
Current: 1.85
0.74
13.74
Price/Median PS Value 1.68
ATRI's Price/Median PS Value is ranked lower than
89% of the 256 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.02 vs. ATRI: 1.68 )
Ranked among companies with meaningful Price/Median PS Value only.
ATRI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.17  Med: 0.61 Max: 1.72
Current: 1.68
0.17
1.72
Price/Peter Lynch Fair Value 3.83
ATRI's Price/Peter Lynch Fair Value is ranked lower than
89% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. ATRI: 3.83 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
ATRI' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.37  Med: 0.81 Max: 3.8
Current: 3.83
0.37
3.8
Price/Graham Number 2.54
ATRI's Price/Graham Number is ranked lower than
54% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.39 vs. ATRI: 2.54 )
Ranked among companies with meaningful Price/Graham Number only.
ATRI' s Price/Graham Number Range Over the Past 10 Years
Min: 0.54  Med: 1.33 Max: 2.58
Current: 2.54
0.54
2.58
Earnings Yield (Greenblatt) (%) 6.10
ATRI's Earnings Yield (Greenblatt) (%) is ranked higher than
80% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. ATRI: 6.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ATRI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 5.7  Med: 9.20 Max: 98.7
Current: 6.1
5.7
98.7
Forward Rate of Return (Yacktman) (%) 9.66
ATRI's Forward Rate of Return (Yacktman) (%) is ranked higher than
51% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.84 vs. ATRI: 9.66 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ATRI' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -14.4  Med: 16.20 Max: 68
Current: 9.66
-14.4
68

More Statistics

Revenue(Mil) $146
EPS $ 15.28
Beta0.88
Short Percentage of Float2.67%
52-Week Range $315.01 - 428.85
Shares Outstanding(Mil)1.82

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Atrion Corp is incorporated in Delaware. The Company and its subsidiaries develop and manufacture products, mainly for medical applications. Its medical products include fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include proprietary valves that promote infection control and needle safety. It has developed a variety of luer syringe check valves and one-way valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, catheter and other applications. It also makes tubing clamps in a variety of materials and colors that are compatible with various grades of tubing and sterilization processes, and produce specialized intravenous sets for use in numerous applications including anesthesia and oncology. Its cardiovascular products include MPS2 Myocardial Protection System, or MPS2, a proprietary technology that delivers essential fluids and medications to the heart during open-heart surgery. The MPS2 integrates key functions relating to the delivery of solutions to the heart, such as varying the rate and ratio of oxygenated blood, crystalloid, potassium and other additives, and controlling temperature, pressure and other variables to allow simpler, more flexible management of this process, indicating improved patient outcomes. The MPS2 is the only device used in open-heart surgery that allows for the mixing of drugs into the bloodstream without diluting the blood. The MPS2 employs pump, temperature control and microprocessor technologies and includes a line of disposable products. It also develop and manufacture other cardiovascular products such as cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in minimally invasive surgical procedures; inflation devices for balloon catheter dilation, stent deployment and fluid dispensing; as well as products used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels. The Company is a manufacturer of contact lens disinfection cases. It also manufacture a proprietary line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Nasolacrimal duct obstruction can cause a condition called epiphora, or chronic tearing. People affected by this condition experience excessive and uncontrollable tearing and often encounter infection as a result of nasolacrimal blockage. In addition, it manufactures and sells a line of products designed for safe needle and scalpel blade containment. It is also the manufacturer of inflation systems and valves used in marine and aviation safety products. It manufactures inflation systems and valves for products such as life vests, life rafts, inflatable boats, survival equipment, and other inflatable structures. It also produce one-way and two-way pressure relief valves for use on electronics cases, munitions cases, pressure vessels,
» More Articles for ATRI

Headlines

Articles On GuruFocus.com
3 Cheap Health Care Dividend Stocks with Huge Potential to Grow Dividends Oct 02 2013 
Billionaires Hold Three Undervalued, Predictable Stocks with Yield Sep 16 2013 
26 Stocks Raised Dividends Over the Past Week Aug 18 2013 
My 4 Favorite Dividend Contenders with Highest Dividend Growth Potential May 24 2013 
Atrion Corporation: Track Record of Delivery Dec 03 2012 
How to Look Beyond Dividend Increases Aug 27 2012 
9 Dividend Stocks Providing Positive Feedback Aug 22 2011 
Guru Stocks Raising Dividends: ITC, PCBK, ATRI, NDSN Aug 22 2011 
ATRION Corp. Reports Operating Results (10-Q) Nov 04 2010 
3 Signs of an Impending Dividend Cut Aug 09 2010 

More From Other Websites
Atrion Corp. – Value Analysis (NASDAQ:ATRI) : February 11, 2016 Feb 11 2016
Atrion Corp. breached its 50 day moving average in a Bullish Manner : February 11, 2016 Feb 11 2016
13 Best Small- and Mid-Cap Stocks to Buy for 2016 Jan 03 2016
Atrion Corp. breached its 50 day moving average in a Bullish Manner : December 23, 2015 Dec 23 2015
Atrion Corp. Earnings Analysis: Q3, 2015 By the Numbers Dec 17 2015
ATRION CORP Financials Dec 08 2015
Atrion Corporation Declares Quarterly Cash Dividend Nov 13 2015
Atrion Corporation Declares Quarterly Cash Dividend Nov 13 2015
Atrion Corp. breached its 50 day moving average in a Bullish Manner : November 10, 2015 Nov 10 2015
ATRION CORP Files SEC form 10-Q, Quarterly Report Nov 06 2015
ATRION CORP Files SEC form 8-K, Financial Statements and Exhibits Nov 05 2015
Atrion Reports Third Quarter Results Nov 05 2015
Atrion Corp. Q2 Earnings, 2015 Aug 25 2015
ATRION CORP Files SEC form 8-K, Results of Operations and Financial Condition Aug 04 2015
Atrion Reports Second Quarter Results Aug 04 2015
Atrion Corporation Increases Quarterly Cash Dividend by 20% Aug 04 2015
Atrion Reports Second Quarter Results Aug 04 2015
Atrion Corporation Increases Quarterly Cash Dividend by 20% Aug 04 2015
ATRION CORP Files SEC form 8-K, Amendment or Waiver to Code of Ethics, Submission of Matters to a... May 22 2015
Atrion Corporation Declares Quarterly Cash Dividend May 21 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK